ICNBs for Post-op Pain in Breast Surgery

Christine M. Kleinert Institute for Hand and Microsurgery

Status and phase: Unknown; Phase 4

Conditions: Length of Stay; Pain, Postoperative

Treatments: Drug: Bupivacaine Hydrochloride

Study type: Interventional

Funder types: Other

Identifiers

NCT04606836

20.0781

Details and patient eligibility

About

The authors will conduct this study to analyze the effectiveness of peri-operative intercostal nerve blocks (ICNBs) in reducing acute postoperative pain after reconstructive breast surgery and mammoplasty and how it affects the length of hospital stay.

Enrollment: 40 estimated patients

Sex: Female

Ages: 20 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiologists Classification (ASA Class) 3 and below.
• Bilateral or unilateral breast surgery including cancer extirpation, reconstruction (implant and expander), oncoplastic surgery (<200 gm), breast augmentation and breast reduction, etc.

Exclusion criteria

• Patients who refuse local anesthesia.
• Patients who cannot receive local anesthesia.
• Below the age of 20 and above the age of 70.
• Patients requiring reoperation due to complications of mammoplasty or another breast surgery.
• Poorly controlled diabetics, uncontrolled hypertension, heart disease, arrhythmias, diagnosed with bipolar and generalized anxiety disorders.

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Prospective Cases

Experimental group

Description:

These cases will be recruited prospectively, and receive the intercostal nerve block(s) on operated site(s). Peri-operative injections of 30 ml of 0.25% Bupivacaine each, injected over the 4th, 5th, and 6th ribs on the operated site(s).

Treatment:

Drug: Bupivacaine Hydrochloride

Retrospective Controls

No Intervention group

Description:

Controls will be gathered retrospectively from chart reviews where patient did not receive a intercostal nerve blocker bilaterally.